Post Profile






Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
read more

share

Related Posts


NICE backs cut-price Novartis leukaemia drug | Reuters

Medical / Pharmaceutical : PharmaGossip

NICE backs cut-price Novartis leukaemia drug | Reuters (Reuters) - Leukaemia drug Tasigna has been backed by Britain's healthcare cost watchdog after its maker Novartis agreed to discount the treatment's cost of more than 30,000 pou...

Emerging Markets! Russian police search Novartis, Teva offices | Reuters

Medical / Pharmaceutical : PharmaGossip

MOSCOW, July 5 (Reuters) - Russian police on Tuesday searched the offices of four pharmaceutical companies in Moscow, including Swiss drug maker Novartis AG and Israel-based Teva. The website of business daily Vedomosti quoted a pol...

NICE says No to Novartis MS pill | Reuters

Medical / Pharmaceutical : PharmaGossip

(Reuters) - Novartis's multiple sclerosis pill Gilenya, one of its biggest new drug hopes, has been rejected by healthcare cost-effectiveness watchdog NICE, which judges it not worth using on the state health service. The National I...

Optus Fined $5.26 Million For Misleading Broadband Advertising

Lifestyle / Productivity : Lifehacker Australia

The Australian Competition and Consumer Commission (ACCC) has been taking a hard line on misleading broadband advertising for a while now, but this is its biggest penalty yet: Optus has been fined $5.26 million for misleading advert...

ACCC Fines Optus For Misleading ‘Max Cap’ Advertisements

Lifestyle / Productivity : Lifehacker Australia

If there’s one thing that regulator the Australian Competition and Consumer Commission (ACCC) won’t stand for, it’s misleading claims about how much a service will cost or what it includes. Last year, it took Optus to court for adve...

Comments


Copyright © 2016 Regator, LLC